Crossmark

Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors

Published Online: 2024-06-24

Authors

Wang, Xinjing

Wang, Wei

Zou, Siyi

Xu, Zhiwei

Cao, Dan

Zhang, Shuai

Wei, Minzhi

Zhan, Qian

Wen, Chenlei

Li, Fanlu

Chen, Hao

Fu, Da

Jiang, Lingxi

Zhao, Ming

Shen, Baiyong
License Information

Text and Data Mining valid from 2024-06-24

Version of Record valid from 2024-06-24
More Information

Article History

Received: 13 January 2024

Accepted: 3 June 2024

First Online: 24 June 2024

Competing interests

: The authors declare no competing interests.

Document is current